Volition appoints dr andrew retter as chief medical officer

Henderson, nev. , march 19, 2024 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, has appointed dr andrew retter as its chief medical officer, effective april 1, 2024.

VNRX Ratings Summary

VNRX Quant Ranking